These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 32259300
1. Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain. Varnäs K, Stepanov V, Halldin C. Synapse; 2020 Oct; 74(10):e22157. PubMed ID: 32259300 [Abstract] [Full Text] [Related]
2. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain. Nabulsi NB, Mercier J, Holden D, Carré S, Najafzadeh S, Vandergeten MC, Lin SF, Deo A, Price N, Wood M, Lara-Jaime T, Montel F, Laruelle M, Carson RE, Hannestad J, Huang Y. J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175 [Abstract] [Full Text] [Related]
3. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers. Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K, Seibyl JP, Tamagnan GD, Barret O. Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043 [Abstract] [Full Text] [Related]
8. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11 C]UCB-J positron emission tomography study. Finnema SJ, Toyonaga T, Detyniecki K, Chen MK, Dias M, Wang Q, Lin SF, Naganawa M, Gallezot JD, Lu Y, Nabulsi NB, Huang Y, Spencer DD, Carson RE. Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949 [Abstract] [Full Text] [Related]
9. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [11C]UCB-J. Toyonaga T, Khattar N, Wu Y, Lu Y, Naganawa M, Gallezot JD, Matuskey D, Mecca AP, Pittman B, Dias M, Nabulsi NB, Finnema SJ, Chen MK, Arnsten A, Radhakrishnan R, Skosnik PD, D'Souza DC, Esterlis I, Huang Y, van Dyck CH, Carson RE. Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1012-1022. PubMed ID: 37955791 [Abstract] [Full Text] [Related]
14. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity. Patel S, Knight A, Krause S, Teceno T, Tresse C, Li S, Cai Z, Gouasmat A, Carroll VM, Barret O, Gottmukkala V, Zhang W, Xiang X, Morley T, Huang Y, Passchier J. Mol Imaging Biol; 2020 Aug; 22(4):832-841. PubMed ID: 31728839 [Abstract] [Full Text] [Related]
17. In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease. Xiong M, Roshanbin S, Rokka J, Schlein E, Ingelsson M, Sehlin D, Eriksson J, Syvänen S. Neuroimage; 2021 Oct 01; 239():118302. PubMed ID: 34174391 [Abstract] [Full Text] [Related]
18. Validation and noninvasive kinetic modeling of [11C]UCB-J PET imaging in mice. Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat Š, Wyffels L, Stroobants S, Mrzljak L, Dominguez C, Liu L, Skinbjerg M, Munoz-Sanjuan I, Staelens S. J Cereb Blood Flow Metab; 2020 Jun 01; 40(6):1351-1362. PubMed ID: 31307287 [Abstract] [Full Text] [Related]